Loss of TIMP3 underlies diabetic nephropathy via FoxO1/STAT1 interplay
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
ADAM17 and its inhibitor TIMP3 are involved in nephropathy, but their role in diabetic kidney disease (DKD) is unclear. Diabetic Timp3 −/− mice showed increased albuminuria, increased membrane thickness and mesangial expansion. Microarray profiling uncovered a significant reduction of Foxo1 expression in diabetic Timp3 −/− mice compared to WT, along with FoxO1 target genes involved in autophagy, while STAT1, a repressor of FoxO1 transcription, was increased. Re‐expression of Timp3 in Timp3 −/− mesangial cells rescued the expression of Foxo1 and its targets, and decreased STAT1 expression to control levels; abolishing STAT1 expression led to a rescue of FoxO1, evoking a role of STAT1 in linking Timp3 deficiency to FoxO1. Studies on kidney biopsies from patients with diabetic nephropathy confirmed a significant reduction in TIMP3, FoxO1 and FoxO1 target genes involved in autophagy compared to controls, while STAT1 expression was strongly increased. Our study suggests that loss of TIMP3 is a hallmark of DKD in human and mouse models and designates TIMP3 as a new possible therapeutic target for diabetic nephropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“restoration of TIMP3 expression in GMCs from Timp3−/− mice by transfection with a Timp3 adenovirus reversed the impairment in autophagy.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [160]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In cultured GMCs exposed to high-glucose, Timp3 deletion suppressed autophagy by reducing the expression of FOXO1a and its target ATG genes”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [160]
The cited source says what the claim attributes to it.
In the citing paper
“Timp3 deletion exacerbated diabetic kidney injury in mice160.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [160]
In the citing paper
“The metalloproteinase inhibitor 3 gene (Timp3) was downregulated in the kidney of STZ-induced diabetic mice and in patients with diabetes, as well as in GMCs treated with high glucose”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [160]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418 · cited 1×
“…be induced by intracellular stresses that are involved in the pathogenesis of diabetic nephropathy including hypoxia or ER stress (Kume et al, 2012; Mizushima & Komatsu, 2011), and plays an important role as a survival factor especially in post-mitotic cells such as podocytes (Fogo, 2011; Godel et…”
[9] TM4 Microarray Software Suite
Saeed, A. I., Bhagabati, N. K., Braisted, J. C., Liang, W., Sharov, V., Howe, E. A., Li, J., Thiagarajan, M., White, J. A., & Quackenbush, J. (2006) · Methods in Enzymology · doi:10.1016/s0076-6879(06)11009-5 · Cited by 1,983 · cited 1×
“Heatmaps and hierarchical clusters were created using MeV 4.4 (MultiExperiment Viewer, TM4 suite; Saeed et al, 2006).”
InfluentialZhao, J., Brault, J. J., Schild, A., Cao, P., Sandri, M., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.004 · Cited by 1,489 · cited 1×
“…and FoxO3A target genes were shown to be involved in autophagic protection of skeletal myocytes, cardiomyocytes and neurons from stress conditions (Hariharan et al, 2010; Masiero et al, 2009; Medema & Jaattela, 2010; Sengupta et al, 2009; van der Vos et al, 2011; Xu et al, 2011; Zhao et al, 2007).”
Autophagy is required to maintain muscle mass.
Masiero, E., Agatea, L., Mammucari, C., Blaauw, B., Loro, E., Komatsu, M., Metzger, D., Reggiani, C., Schiaffino, S., & Sandri, M. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.10.008 · Cited by 1,282 · cited 1×
“…and FoxO3A target genes were shown to be involved in autophagic protection of skeletal myocytes, cardiomyocytes and neurons from stress conditions (Hariharan et al, 2010; Masiero et al, 2009; Medema & Jaattela, 2010; Sengupta et al, 2009; van der Vos et al, 2011; Xu et al, 2011; Zhao et al, 2007).”
ADAMs: key components in EGFR signalling and development
Blobel, C. P. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1548 · Cited by 1,090 · cited 1×
“ADAM17, also known as TNF-a converting enzyme (TACE), mediates the shedding of TNF-a and its receptors (TNFRI and II), adhesion molecules ( L -selectin, VCAM), and several EGFR ligands, such as amphiregulin, TGF-a and heparin-binding EGF-Research like growth factor (HB-EGF; Blobel, 2000, 2005).”
The Stages in Diabetic Renal Disease: With Emphasis on the Stage of Incipient Diabetic Nephropathy
Mogensen, C. E., Christensen, C. K., & Vittinghus, E. (1983) · Diabetes · doi:10.2337/diab.32.2.s64 · Cited by 967 · cited 1×
“Poor glycaemic control and elevated systolic blood pressure exacerbate proteinuria and renal injury that may culminate in end-stage renal disease (Lane et al, 1990; Mogensen et al, 1983).”
Redox Regulation of Forkhead Proteins Through a p66shc -Dependent Signaling Pathway
Nemoto, S., & Finkel, T. (2002) · Science · doi:10.1126/science.1069004 · Cited by 818 · cited 2×
“…2D FoxO1 regulation in diabetic Timp3 (cid:1) / (cid:1) kidneys Giving the importance of FoxO1 in regulating cell survival and oxidative stress (Nemoto & Finkel, 2002), and renal neoplastic cell proliferation (Gan et al, 2010), we next focused on FoxO1 regulation in STZ-Timp3 (cid:1) / (cid:1)…”
Hartleben, B., Gödel, M., Meyer-Schwesinger, C., Liu, S., Ulrich, T., Köbler, S., Wiech, T., Grahammer, F., Arnold, S. J., Lindenmeyer, M. T., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39492 · Cited by 721 · cited 1×
“…including hypoxia or ER stress (Kume et al, 2012; Mizushima & Komatsu, 2011), and plays an important role as a survival factor especially in post-mitotic cells such as podocytes (Fogo, 2011; Godel et al, 2011; Hartleben et al, 2010; He et al, 2010; Inoki et al, 2011; Kume et al, 2010; Nath, 2010).”
Hariharan, N., Maejima, Y., Nakae, J., Paik, J., DePinho, R. A., & Sadoshima, J. (2010) · Circulation Research · doi:10.1161/circresaha.110.227371 · Cited by 692 · cited 1×
“…and FoxO3A target genes were shown to be involved in autophagic protection of skeletal myocytes, cardiomyocytes and neurons from stress conditions (Hariharan et al, 2010; Masiero et al, 2009; Medema & Jaattela, 2010; Sengupta et al, 2009; van der Vos et al, 2011; Xu et al, 2011; Zhao et al, 2007).”
Qi, J. H., Ebrahem, Q., Moore, N., Murphy, G., Claesson-Welsh, L., Bond, M., Baker, A., & Anand-Apte, B. (2003) · Nature Medicine · doi:10.1038/nm846 · Cited by 658 · cited 2×
“Through gene expression profiling of Timp3 (cid:1) / (cid:1) diabetic kidneys, our study confirms that many critical mediators of inflammation and proliferation are found up-regulated, although we did not observe a perturbation of the VEGFR pathway that has been reported to bind TIMP3 (Qi et al, 2003).”
Cited by
The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases
Cabral-Pacheco, G. A., Garza-Veloz, I., Castruita-De la Rosa, C., Ramirez-Acuña, J. M., Perez-Romero, B. A., Guerrero-Rodriguez, J. F., Martinez-Avila, N., & Martinez-Fierro, M. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249739 · Cited by 1,820
“MicroRNAs (miRs) play important roles in the initiation and progression of many pathological processes, such as diabetic nephropathy [69] and retinopathy [112].”
BackgroundAutophagy in kidney homeostasis and disease
Tang, C., Livingston, M. J., Liu, Z., & Dong, Z. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0309-2 · Cited by 496
The return of the nucleus: transcriptional and epigenetic control of autophagy
Füllgrabe, J., Klionsky, D. J., & Joseph, B. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3716 · Cited by 466
Autophagy in diabetic nephropathy
Ding, Y., & Choi, M. E. (2015) · Journal of Endocrinology · doi:10.1530/joe-14-0437 · Cited by 306
“Furthermore, knockdown of TIMP3 in mesangial cells, either by shRNA or genetic deletion in primary mesangial cells obtained from Timp3-null mice, recapitulated FOXO1 downregulation in vivo and inhibition of autophagy (Fiorentino et al. 2013).”
BackgroundInfluentialRegulation of autophagy by stress-responsive transcription factors
Pietrocola, F., Izzo, V., Niso-Santano, M., Vacchelli, E., Galluzzi, L., Maiuri, M. C., & Kroemer, G. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.05.008 · Cited by 268
Metadata
- Authors
- Fiorentino, L., Cavalera, M., Menini, S., Marchetti, V., Mavilio, M., Fabrizi, M., Conserva, F., Casagrande, V., Menghini, R., Pontrelli, P., Arisi, I., D'Onofrio, M., Lauro, D., Khokha, R., Accili, D., Pugliese, G., Gesualdo, L., Lauro, R., & Federici, M.
- Affiliations
- University of Rome Tor Vergata (IT)
- Sapienza University of Rome (IT)
- University of Bari Aldo Moro (IT)
- European Brain Research Institute (IT)
- University of Toronto (CA)
- Columbia University (US)
- Corresponding author
- Federici, Massimo
- ORCID
- Venue
- EMBO Molecular Medicine
- Published
- 2013-02-12
- Volume
- 5
- Issue
- 3
- Pages
- 441-455
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- PMC
- PMC3598083
- OpenAlex
- W1917997699
- Cited by
- 98
- References
- 53
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 4 · 2023: 6 · 2022: 6 · 2021: 10 · 2020: 6 · 2019: 12 · 2018: 5 · 2017: 5 · 2016: 9 · 2015: 7 · 2014: 10 · 2013: 9
- FWCI
- 8.80
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/3.0/ (tdm)
- creativecommons.org/licenses/by/3.0/ (vor)
- Locations
- EMBO Molecular Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK057539)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
- Keywords
- TIMP-3, diabetic nephropathy, FOXO1, STAT1, ADAM17, autophagy, albuminuria, mesangial expansion, therapeutic target
- MeSH terms
- Forkhead Box Protein O1, Albuminuria, Animals, Autophagy, Biopsy, Cell Line, Diabetes Mellitus, Experimental, Diabetic Nephropathies, Gene Expression Regulation, Humans, Kidney Glomerulus, Transfection, Signal Transduction, Mice, Knockout, Tissue Inhibitor of Metalloproteinase-3, Gene Expression Profiling, RNA Interference, Mesangial Cells, STAT1 Transcription Factor, Mice, Forkhead Transcription Factors, Primary Cell Culture
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Loss of TIMP3 underlies diabetic nephropathy via FoxO1/STAT1 interplay. https://app.cochat.ai/papers/10.1002/emmm.201201475
- The paper
- Fiorentino, L., Cavalera, M., Menini, S., Marchetti, V., Mavilio, M., Fabrizi, M., Conserva, F., Casagrande, V., Menghini, R., Pontrelli, P., Arisi, I., D'Onofrio, M., Lauro, D., Khokha, R., Accili, D., Pugliese, G., Gesualdo, L., Lauro, R., & Federici, M. (2013). Loss of TIMP3 underlies diabetic nephropathy via FoxO1/STAT1 interplay. EMBO Molecular Medicine. https://doi.org/10.1002/emmm.201201475
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.